课题基金 / 基金详情

新型抗菌肽嵌合体M(27-39)-HTPP靶向抗HCC作用及机制研究

批准号:
32070509
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
卢雪梅
依托单位:
学科分类:
动物资源与保护
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
卢雪梅

项目摘要

结项摘要

卢雪梅的其他基金

相似基金

相关文献

中文摘要
家蝇作为一种卫生害虫,其自身独特免疫防御系统为药用活性分子发掘提供了丰富的资源。前期,课题组对家蝇抗菌肽cecropin进行构效关系研究时获得抗肝癌(HCC)活性更高、分子更小的衍生肽M27-39,并利用从疟原虫CSP筛选获得的肝靶向穿膜肽HTPP对其进行分子改造,成功构建新型靶向抗菌肽嵌合体M(27-39)-HTPP。体外实验证实M(27-39)-HTPP不仅可特异靶向肝脏并递送至癌细胞内,且抗HCC效果显著增强,但其体内抗HCC作用及具体机制不明确。本项目拟以肝癌原位种植瘤裸鼠为模型,研究M(27-39)-HTPP体内靶向抗HCC效果,在此基础上,通过研究其与肝癌细胞表面分子HSPG的关系阐明靶向机制,并围绕肝癌发生发展关键事件,通过针对不同潜在靶位点的实验设计,探讨其靶向抗HCC分子机制,为开发拥有自主知识产权的新型靶向抗肝癌药物提供基础,也为昆虫来源活性分子的多功能研究拓展视野。
英文摘要
Musca domestica, although a sanitary pest, has extremely unique immune defense system, which provides rich resources for the excavation of the medicinal active molecules. In carrying out the structure-activity studies of Musca domestica antimicrobial peptide cecropin (MDC), we have screened a small peptide M27-39, a derivative peptide with higher activity against hepatic carcinoma (HCC) and smaller molecular size than MDC. We have also modified the peptide M27-39 by using HTPP as a targeting vector to construct the targeted antimicrobial peptide chimera M(27-39)-HTPP. In previous studies, it was confirmed that M(27-39)-HTPP not only displayed liver-targeting function and could be delivered into the hepatoma cell, but also its anti-HCC effect was significantly enhanced compared with M27-39 by in vitro experiments. But the anti-HCC effect of M(27-39)-HTPP in vivo and the mechanism of the anti-HCC effect still need to clarify. This project intends to investigate anti-HCC activity of M(27-39)-HTPP in vivo using situ implantation of human hepatocellular carcinoma in nude mice at first. And then, we will clarify the targeting mechanism of M(27-39)-HTPP by studying its relationship with hepatoma cell surface molecule-HSPG. Finally, according to the key events in the process of hepatocellular carcinoma development, we will design the experiment aiming at different potential targets to intend to explore the molecular mechanism of M(27-39)-HTPP against HCC. If we can achieve the desired results, we will provide a new drug candidate molecule with the independence intelligent property right for the development of targeting anti-HCC drugs, and we will also expand the field of research for the multi-function study of active molecules from insect.
肝细胞癌(Hepatocellular carcinoma,HCC)是常见的高度恶性肿瘤,全球每年HCC新发患者高达55.1万例,我国为肝癌高发区域,死亡率高居我国肿瘤死亡率的第二位。家蝇作为一种卫生害虫,其自身独特免疫防御系统为药用活性分子发掘提供了丰富的资源。前期,课题组对家蝇抗菌肽cecropin进行构效关系研究时获得抗肝癌(HCC)活性更高、分子更小的衍生肽M27-39。疟原虫等特定病原体对宿主组织或细胞具有高度选择性,给高效特异的靶向制剂研究带来了新的思路。利用从疟原虫环子孢子蛋白 (Circumsporozoite protein,CSP) 中筛选获得的高效特异肝靶向穿膜肽(Hepatocyte-targeting and penetrating peptide,HTPP),对M27-39进行分子改造,成功构建新型靶向抗菌肽嵌合体M(27-39)-HTPP,利用肝癌细胞株和原位种植瘤模型,体内外验证其可特异性靶向肝癌并递送至癌细胞内,多靶点协同发挥抗HCC作用。在此基础上,通过研究其与肝癌细胞表面分子HSPG的关系阐明其靶向机制,并围绕肝癌发生发展的关键事件对其机制进行探讨,结果提示抗菌肽嵌合体M(27-39)-HTPP 抗肝癌分子机制可能与线粒体相关的细胞凋亡途径相关。项目的顺利实施为开发拥有自主知识产权的新型靶向抗肝癌药物奠定基础,也为昆虫来源活性分子的多功能研究拓展视野。
家蝇抗菌肽cecropin抗HBV作用及其机制研究
  • 批准号:
    31501894
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2015
  • 负责人:
    卢雪梅
  • 依托单位:
国内基金
海外基金